Xufeng Jiang

Dr. Xufeng Jiang


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2023 in Gut Microbes
Verified
Journal Article
Open access
XQXiaohang Qian
Xiaohang Qian
WHWangxi Hai
Wangxi Hai
SCSiyue Chen
Siyue Chen
MZMiao Zhang
Miao Zhang
XJXufeng Jiang
Xufeng Jiang
HTHuidong Tang
Huidong Tang
Numerous studies have described the notable impact of gut microbiota on the brain in Alzheimer's disease (AD) via the gut - brain axis. However, the molecular mechanisms underlying the involvement of gut microbiota in the development of AD are limited. This study aimed to explore the potential mechanisms of gut microbiota in AD by integrating multi-omics data. In this study, APP/PS1 and WT mice at nine months of age were used as study mouse model. Cognitive function was assessed using the Morris water maze test. The levels of Aβ plaque and neuroinflammation in the brain were detected using immunofluorescence and PET/CT. In addition, we not only used 16S rRNA gene sequencing and metabolomics to explore the variation characteristics of gut microbiota and serum metabolism abundance, but also combined spatial metabolomics and transcriptomics to explore the change in the brain and identify their potential correlation. APP/PS1 mice showed significant cognitive impairment and amyloid-β deposits in the brain. The abundance of gut microbiota was significantly changed in APP/PS1 mice, including decreased Desulfoviobrio, Enterococcus, Turicibacter, and Ruminococcus and increased Pseudomonas. The integration of serum untargeted metabolomics and brain spatial metabolomics showed that glycerophospholipid metabolism was a common alteration pathway in APP/PS1 mice. Significant proliferation and activation of astrocyte and microglia were observed in APP/PS1 mice, accompanied by alterations in immune pathways. Integration analysis and fecal microbiota transplantation (FMT) intervention revealed potential association of gut microbiota, host glycerophospholipid metabolism, and neuroinflammation levels in APP/PS1 mice.

6 October 2023 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Open access
PDF file
MZMiao Zhang
Miao Zhang
XQXiao-Hang Qian
Xiao-Hang Qian
JHJialin Hu
Jialin Hu
YZYaoyu Zhang
Yaoyu Zhang
XLXiaozhu Lin
Xiaozhu Lin
BLBiao Li
Biao Li
Purpose: Despite the revealed role of immunological dysfunctions in the development and progression of Alzheimer’s disease (AD) through animal and postmortem investigations, direct evidence regarding the impact of genetic factors on microglia response and amyloid-β (Aβ) deposition in AD individuals is lacking. This study aims to elucidate this mechanism by integrating transcriptomics and TSPO, Aβ PET imaging in clinical AD cohort. Methods: We analyzed 85 patients with PET/MR imaging for microglial activation (TSPO, [18F]DPA-714) and Aβ ([18F]AV-45) within the prospective Alzheimer’s Disease Immunization and Microbiota Initiative Study Cohort (ADIMIC). Immune-related differentially expressed genes (IREDGs), identified based on AlzData, were screened and verified using blood samples from ADIMIC. Correlation and mediation analyses were applied to investigate the relationships between immune-related genes expression, TSPO and Aβ PET imaging. Results: TSPO uptake increased significantly both in aMCI (P < 0.05) and AD participants (P < 0.01) and showed a positive correlation with Aβ deposition (r = 0.42, P < 0.001). Decreased expression of TGFBR3, FABP3, CXCR4 and CD200 was observed in AD group. CD200 expression was significantly negatively associated with TSPO PET uptake (r =—0.33, P = 0.013). Mediation analysis indicated that CD200 acted as a significant mediator between TSPO uptake and Aβ deposition (total effect B = 1.92, P = 0.004) and MMSE score (total effect B =—54.01, P = 0.003). Conclusion: By integrating transcriptomics and TSPO PET imaging in the same clinical AD cohort, this study revealed CD200 played an important role in regulating neuroinflammation, Aβ deposition and cognitive dysfunction.

1 October 2016
Verified
Journal Article
Closed access
JTJianjing Tong
Jianjing Tong
YZYaru Zou
Yaru Zou
JJJie Jiang
Jie Jiang
WSWen Shi
Wen Shi
RTRanjun Tao
Ranjun Tao
WWWeiqing Wang
Weiqing Wang

2 April 2025 in Arthroplasty
Verified
Journal Article
Open access
PDF file
CWChuanlong Wu
Chuanlong Wu
HWHongyi Wang
Hongyi Wang
ZCZhijie Chen
Zhijie Chen
JZJiong Zhang
Jiong Zhang
ZLZhihong Liu
Zhihong Liu
Chuan HeChuan He
Chuan He
Objective: The efficacy of secondary patellar resurfacing (SPR) in alleviating anterior knee pain (AKP) following total knee arthroplasty (TKA) remains uncertain. The purpose of this study was to assess the suitability of SPR using single photon emission computed tomography/computed tomography (SPECT/CT) in conjunction with triple-phase bone scan (TPBS). Methods: We performed a retrospective analysis on a prospectively-enrolled cohort of patients suffering from AKP in the context of TKA. In this cohort, we identified a subset of 17 patients (involving 18 knees), who had unexplained AKP and were potential candidates for secondary patellar resurfacing (SPR). The candidates for SPR were designated the experimental group, and subjects receiving other forms of treatment were referred to as the Control group. The selection for these treatment options was based on the findings from SPECT/CT and triple-phase bone scan (TPBS). Data collection spanned from preoperative to postoperative follow-up periods and encompassed basic demographics, preoperative findings of SPECT/CT plus TPBS, and Knee Society Score (KSS). Results: SPECT/CT and TPBS revealed focal radionuclide concentration in the patella in 12 patients (13 knees) and in other locations in 5 patients (5 knees) with unexplained AKP, complementing the findings from medical history and physical examinations. The Experimental group showed signs of patellar maltracking or early-stage patellofemoral osteoarthritis (OA) following TKA and received SPR treatment. Postoperatively, the objective knee indicators score was significantly higher than preoperative scores (88.46 ± 5.77 vs. 76.38 ± 7.64, P < 0.05). Similarly, the functional activities score was significantly improved postoperatively (74.31 ± 6.68 vs. 50.46 ± 9.01, P < 0.05). Patient satisfaction score was substantially elevated after SPR (33.38 ± 2.87 vs. 17.08 ± 5.69, P < 0.05). The control group mainly included patients who experienced loosening, periprosthetic joint infection (PJI), or instability. These patients received revision surgeries tailored to their individual pathologies and postoperative follow-ups showed favorable outcomes. Conclusions: SPECT/CT in combination with TPBS may serve as a valuable tool for assessing the suitability of SPR for the post-TKA management of unexplained AKP.

7 April 2025
Verified
Journal Article
Closed access
YRYixuan Ren
Yixuan Ren
JCJiamin Chen
Jiamin Chen
CWChao Wang
Chao Wang
XLXiaozhu Lin
Xiaozhu Lin
SCShu Cheng
Shu Cheng
DCDongxu Chen
Dongxu Chen